68 patients Type 2 diabetic patients were recruited from outpatients and hospitalized patients who did not take hypoglycemic drugs. Patients were randomly divided into control and treatment groups. Urinary albumin excretion rate and relationships between glycosylated hemoglobin and blood lipids were also investigated.
After five years total cholesterol was significantly lowered and low density lipoprotein was significantly reduced. High density lipoprotein and triglyceride treatment were significantly different. Urinary albumin excretion rates were increased in the treatment groups. Diabetic nephropathy in the Danshen group was lower than the control group.
Compound Danshen therapy can retard the occurrence and development of diabetic nephropathy, modulate blood lipids.
Comments